Webinar: Unlocking the mysteries of nutrition, treatment and clinical trials:
Spotlight on Pancreatic and Stomach cancers, the silent killers
Friday 27 November 2020 at 11:30am-12:15pm AEST
Pancreatic cancer and Stomach cancer are often called the silent killers. They are difficult to detect and survival rates are tragically low. But more than 6,000 Australians will be diagnosed with one of these diseases this year.
In recognition of pancreatic and stomach cancer awareness month in November, our guest speakers medical oncologist Associate Professor Nick Pavlakis and clinical dietitian Belinda Steer, and moderator Daniel Goulburn OAM, discussed all facets of managing these cancers from study design challenges through to the importance of nutrition during and after treatment.
Webinar: Unlocking the mysteries of Rare Cancers
Friday 18 September 2020 at 11:30am-12:15pm AEST
Why do rare cancers have lower rates of patient survival than common cancers? Join medical oncologist Professor David Goldstein and Rare Cancers Australia CEO Richard Vines as they demystify rare cancers and talk about how to develop research in an area that is critically underfunded. This webinar is being held in collaboration with our friends at Rare Cancers Australia.
Webinar: Unlocking the mysteries of Clinical Trials
Held on 26 June 2020 at 11:00-11:45am AEST
In our first Living Room Series webinar, we discussed clinical trials and how they actually work: from a spark of inspiration to enrolling patients. The webinar was hosted by Dr Lorraine Chantrill, Head of Medical Oncology, Wollongong Hospital and Chair, GI Cancer Institute with Professor Chris Karapetis, Medical Oncologist, Flinders Centre for Innovation in Cancer.
Our hosts drew on their wealth of expertise to discuss how COVID-19 has impacted clinical trials and the care of patients. They also discussed what it actually means to get a clinical trial going and the potential impact on trials at this time and they took a look at hopes and plans for the future to find cures for patients with Gastro-Intestinal (GI) cancer.